Medicare AdvantageCoverageMedium impact
MA11.052e, Ablation of Lung Tumors
Independence Blue Cross·Oncology, Pulmonology, Radiation Oncology·Medical Policy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
Policy MA11.052e establishes coverage and reimbursement guidelines for ablation of lung tumors under Medicare Advantage plans, effective July 28, 2025. This recent policy change requires billing and clinical teams to understand new coverage criteria and reimbursement parameters for lung tumor ablation procedures.
Action Required
By July 28, 2025: Billing team must review the full policy text at the provided URL to identify specific CPT/HCPCS codes, prior authorization requirements, and coverage limitations for lung tumor ablation procedures. Update billing system edits, prior authorization workflows, and provider communication materials accordingly. Oncology and pulmonology staff should be notified of any documentation or clinical requirements. Verify that claims submitted after the effective date comply with the new coverage and reimbursement position. Without proper implementation, claims may be denied or incorrectly reimbursed.